Literature DB >> 26177379

Failed Surgical Weight Loss Does Not Necessarily Mean Failed Metabolic Effects.

Ali Aminian1, Mohammad Jamal1, Toms Augustin1, Ricard Corcelles1, John P Kirwan2, Philip R Schauer1, Stacy A Brethauer1.   

Abstract

The metabolic profile of patients after a failed surgical weight loss procedure is unknown. Long-term clinical outcomes of 31 obese diabetes patients with post-bariatric surgery excess weight loss of ≤25% were assessed. At a median follow-up of 6 years (range, 5-9 years) after surgery, remission and clinical improvement of diabetes occurred in seven (23%) and 13 (42%) patients, respectively. A long-term mean total weight loss of 7.0±4.7% and excess weight loss of 13.7±8.5% were associated with a mean reduction in fasting blood glucose level, from 158.9±66.7 to 128.4±35.3 mg/dL (P=0.03), and a significant decrease in diabetes medication requirements (P<0.001). A significant decrease in systolic blood pressure (11.1±23.4 mm Hg, P=0.01) and level of circulating triglycerides (35.7±73.4 mg/dL, P=0.04) was also observed after surgery. A modest surgical weight loss in the range of 5-10% of initial weight was associated with significant improvement in cardiometabolic risk factors of morbidly obese diabetes patients. The markedly improved glycemic control (65% remission or clinical improvement) may be partly explained by weight-independent antidiabetes mechanisms of certain bariatric surgical procedures.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26177379      PMCID: PMC4808286          DOI: 10.1089/dia.2015.0064

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  16 in total

Review 1.  Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution.

Authors:  David E Cummings; Joost Overduin; Karen E Foster-Schubert
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

2.  Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus.

Authors:  Stacy A Brethauer; Ali Aminian; Héctor Romero-Talamás; Esam Batayyah; Jennifer Mackey; Laurence Kennedy; Sangeeta R Kashyap; John P Kirwan; Tomasz Rogula; Matthew Kroh; Bipan Chand; Philip R Schauer
Journal:  Ann Surg       Date:  2013-10       Impact factor: 12.969

3.  Outcomes of bariatric surgery in type 2 diabetic patients with diminished pancreatic secretory reserve.

Authors:  Ali Aminian; Stacy A Brethauer; Christopher R Daigle; John P Kirwan; Bartolome Burguera; Sangeeta R Kashyap; Philip R Schauer
Journal:  Acta Diabetol       Date:  2014-09-27       Impact factor: 4.280

4.  The long-term effectiveness of a lifestyle intervention in severely obese individuals.

Authors:  Jessica L Unick; Daniel Beavers; Dale S Bond; Jeanne M Clark; John M Jakicic; Abbas E Kitabchi; William C Knowler; Thomas A Wadden; Lynne E Wagenknecht; Rena R Wing
Journal:  Am J Med       Date:  2013-03       Impact factor: 4.965

5.  The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.

Authors:  Francesco Rubino; Antonello Forgione; David E Cummings; Michel Vix; Donatella Gnuli; Geltrude Mingrone; Marco Castagneto; Jacques Marescaux
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

6.  Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.

Authors:  Rena R Wing; Paula Bolin; Frederick L Brancati; George A Bray; Jeanne M Clark; Mace Coday; Richard S Crow; Jeffrey M Curtis; Caitlin M Egan; Mark A Espeland; Mary Evans; John P Foreyt; Siran Ghazarian; Edward W Gregg; Barbara Harrison; Helen P Hazuda; James O Hill; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Maria G Montez; Anne Murillo; David M Nathan; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David Reboussin; Judith G Regensteiner; Amy D Rickman; Donna H Ryan; Monika Safford; Thomas A Wadden; Lynne E Wagenknecht; Delia S West; David F Williamson; Susan Z Yanovski
Journal:  N Engl J Med       Date:  2013-06-24       Impact factor: 91.245

Review 7.  Leptin and the central nervous system control of glucose metabolism.

Authors:  Gregory J Morton; Michael W Schwartz
Journal:  Physiol Rev       Date:  2011-04       Impact factor: 37.312

8.  Prevalence of undiagnosed and inadequately treated type 2 diabetes mellitus, hypertension, and dyslipidemia in morbidly obese patients who present for bariatric surgery.

Authors:  Rouzbeh Mostaedi; Denise E Lackey; Sean H Adams; Stephen A Dada; Zahid A Hoda; Mohamed R Ali
Journal:  Obes Surg       Date:  2014-06       Impact factor: 4.129

9.  Weight loss outcome of revisional bariatric operations varies according to the primary procedure.

Authors:  Robert E Brolin; Ronald P Cody
Journal:  Ann Surg       Date:  2008-08       Impact factor: 12.969

10.  Revisional bariatric surgery: perioperative morbidity is determined by type of procedure.

Authors:  D Stefanidis; K Malireddy; T Kuwada; R Phillips; E Zoog; K S Gersin
Journal:  Surg Endosc       Date:  2013-08-14       Impact factor: 4.584

View more
  14 in total

1.  Total Weight Loss as the Outcome Measure of Choice After Roux-en-Y Gastric Bypass.

Authors:  Ricard Corcelles; Mena Boules; Dvir Froylich; Amani Hag; Christopher R Daigle; Ali Aminian; Stacy A Brethauer; Barto Burguera; Philip R Schauer
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

2.  Older Age Confers a Higher Risk of 30-Day Morbidity and Mortality Following Laparoscopic Bariatric Surgery: an Analysis of the Metabolic and Bariatric Surgery Quality Improvement Program.

Authors:  Ivy N Haskins; Tammy Ju; Ashlyn E Whitlock; Lisbi Rivas; Richard L Amdur; Paul P Lin; Khashayar Vaziri
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

3.  Effect of Gastrogastric Fistula Closure in Type 2 Diabetes.

Authors:  Katherine M Meister; Philip R Schauer; Stacy A Brethauer; Ali Aminian
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

4.  Defining Weight Loss After Bariatric Surgery: a Call for Standardization.

Authors:  Brandon T Grover; Michael C Morell; Shanu N Kothari; Andrew J Borgert; Kara J Kallies; Matthew T Baker
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

Review 5.  Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery.

Authors:  J David Mosinski; John P Kirwan
Journal:  Curr Diab Rep       Date:  2016-06       Impact factor: 4.810

6.  Sensitivity and Specificity of 50% Excess Weight Loss (50%EWL) and Twelve Other Bariatric Criteria for Weight Loss Success.

Authors:  Arnold W van de Laar; A S van Rijswijk; H Kakar; S C Bruin
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

Review 7.  Bariatric Surgery in Obese Patients With Type 1 Diabetes.

Authors:  John P Kirwan; Ali Aminian; Sangeeta R Kashyap; Bartolome Burguera; Stacy A Brethauer; Philip R Schauer
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112

8.  RYGB Produces more Sustained Body Weight Loss and Improvement of Glycemic Control Compared with VSG in the Diet-Induced Obese Mouse Model.

Authors:  Zheng Hao; R Leigh Townsend; Michael B Mumphrey; Christopher D Morrison; Heike Münzberg; Hans-Rudolf Berthoud
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

9.  Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress.

Authors:  J D Mosinski; M R Pagadala; A Mulya; H Huang; O Dan; H Shimizu; E Batayyah; R K Pai; P R Schauer; S A Brethauer; J P Kirwan
Journal:  Acta Physiol (Oxf)       Date:  2015-12-29       Impact factor: 6.311

10.  Primary Inadequate Weight Loss After Roux-en-Y Gastric Bypass Is not Associated with Poor Cardiovascular or Metabolic Outcomes: Experience from a Single Institution.

Authors:  Ivy N Haskins; Ricard Corcelles; Dvir Froylich; Mena Boules; Amani Hag; Bartolome Burguera; Phillip R Schauer; Matthew Kroh; Stacy A Brethauer
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.